Saegis Pharmaceuticals
Half Moon Bay
About Saegis Pharmaceuticals
Saegis Pharmaceuticals is focused on the development of medicines that address behavioral disorders. The company has a pipeline of treatments for central nervous system diseases involving cognitive dysfunction, including Alzheimer’s disease, mild cognitive impairment, attention deficit hyperactivity disorder, and cognitive impairment associated with schizophrenia. It develops CNS therapeutics for patients facing memory loss and cognition deficits associated with aging, psychiatric disorders, and brain trauma. Saegis Pharmaceuticals was founded in 1999 and is based in Half Moon Bay, California.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $44.0M
- Funding stage: M&A
- Last round: Series B (Nov 2003)
- Website: saegispharma.com
- Phone: +1 650-560-0210
Industries & Categories
Biopharma, Biotechnology, Health Care, Medical
Canonical: https://fsome.com/organization/saegis-pharmaceuticals-3167934 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.